Wallace Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Goa., Goa, India, established in 1968.
1968 Goa., Goa, India Active
Last Updated:
Access Report
About Wallace Pharmaceuticals Private Limited

Wallace Pharmaceuticals Private Limited, a active private limited company, was established on 02 February 1968 in Goa., Goa, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239GA1968PTC000080. Registered under ROC Roc Goa. it is unlisted. It has an authorized capital of ₹5.50 Cr and a paid-up capital of ₹2.65 Cr.

Formerly known as Carter Wallace Private Limited, Carter Wallace Limited. It upholds a compliant status. Employing 1,788 professional, Its leadership includes Rajashekhar Rayanagoudar Basanagouda (Whole-Time Director), Vinay Pinto (Director), Rashmi Menezes (Managing Director). Past directors included Rajashekhar Rayanagoudar Basanagouda, Vithal Purushottam Sawant, Rashmi Menezes. It holds ₹45.00 Cr open charges and ₹208.79 Cr settled loans. Its latest AGM occurred on 29 October 2024, with the balance sheet filed on 31 March 2024. It is based at 3 Rd Floor, Dtc Building,Patto Plaza, Edc Complex,Panaji-, Goa., Goa, 403001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239GA1968PTC000080

  • Registration Number

    000080

  • Incorporation Date

    02 February 1968

  • Authorized Capital

    ₹5.50 Cr

  • Paid-Up Capital

    ₹2.65 Cr

  • ROC Code

    Roc Goa

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.50 Cr
  • Paid Up Capital ₹ 2.65 Cr
  • Company Age 58 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 45.00 Cr
  • Satisfied Charges ₹ 208.79 Cr
  • Revenue Growth **** 15.62%
  • Profit Growth **** 22.01%
  • Ebitda **** 14.10%
  • Net Worth 26.31%
  • Total Assets **** 25.48%
Company report

Wallace Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Wallace Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Wallace Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rajashekhar Rayanagoudar Basanagouda Whole-Time Director 01 Feb 2025 Current
Vinay Pinto Director 25 Feb 2002 Current
Rashmi Menezes Managing Director 31 May 2001 Current
Pankaj Kumar Director 22 Jun 2020 Current
Maria Emilia Dias Menezes Director 09 Dec 1997 Current
Cesar Mauricio Jose De Menezes Managing Director 15 Jun 2005 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 01 Feb 2025 Past
Pramod Abcsdd Additional Director 10 Sep 2013 Past
Pramod Abcsdd Director 01 Apr 2015 Past
Pramod Abcsdd Director 23 Dec 2016 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Director 23 Dec 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Wallace Pharmaceuticals.

Wallace Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.62% increase. The company also saw a substantial improvement in profitability, with a 22.01% increase in profit. The company's net worth Soared by an impressive increase of 26.31%.

Wallace Pharmaceuticals revenue growth over time
Wallace Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 15.62%
*******
*******
*******
*******
Revenue from Operations
*******
 15.98%
*******
*******
*******
*******
Total Assets
*******
 25.48%
*******
*******
*******
*******
Profit or Loss
*******
 22.01%
*******
*******
*******
*******
Net Worth
*******
 26.31%
*******
*******
*******
*******
EBITDA
*******
 14.10%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Wallace Pharmaceuticals?

In 2023, Wallace Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹450,000,000.00

Satisfied Charges

₹2,087,860,000.00

Charges Breakdown by Lending Institutions
  • Yes Bank Limited : 45.00 Cr
Latest Charge Details
Date Lender Amount Status
16 Mar 2016 Yes Bank Limited ₹45.00 Cr Open
28 Sep 2023 Yes Bank Limited ₹100.00 Cr Satisfied
31 Mar 1999 Bank Of Baroda ₹2.00 Cr Satisfied
21 Jan 1999 Bank Of Baroda ₹2.00 M Satisfied
21 Jan 1999 Bank Of Baroda ₹1.85 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Wallace Pharmaceuticals?

Wallace Pharmaceuticals has a workforce of 1788 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Wallace Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wallace Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Wallace Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Rajashekhar Rayanagoudar Basanagouda was appointed as a Whole-time director was appointed as a Whole-time director on 01 Feb 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.

  • Director Appointment

    Sandeep Inamdar was appointed as a Whole-time director was appointed as a Whole-time director on 01 Feb 2025 & has been associated with this company since 1 year 1 month . was recorded as a recent event.

  • Annual General Meeting

    Wallace Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Oct 2024 as per latest MCA records. was recorded as a recent event.

  • Charges

    A charge registered on 28 Sep 2023 via Charge ID 100791627 with Yes Bank Limited was fully satisfied on 13 May 2024. was recorded as a recent event.

  • Balance Sheet

    Wallace Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Goa. was recorded as a recent event.

  • Charges

    Progress on A charge with Yes Bank Limited of Rs. 45.00 Cr registered on 16 Mar 2016 with Charge ID 100022627 was modified on 22 Mar 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Wallace Pharmaceuticals Private Limited?

The CIN of Wallace Pharmaceuticals Private Limited is U24239GA1968PTC000080.

Where is Wallace Pharmaceuticals Private Limited headquartered?

Wallace Pharmaceuticals Private Limited is headquartered at 3 Rd Floor, Dtc Building,Patto Plaza, Edc Complex,Panaji-, Goa., Goa, 403001.

When was Wallace Pharmaceuticals Private Limited incorporated?

Wallace Pharmaceuticals Private Limited was incorporated on 02 February 1968.

Who are the current directors of Wallace Pharmaceuticals Private Limited?

The current directors of Wallace Pharmaceuticals Private Limited are

What is the primary industry of Wallace Pharmaceuticals Private Limited?

The primary industry of Wallace Pharmaceuticals Private Limited is Manufacturing.

Is Wallace Pharmaceuticals Private Limited a listed company?

Wallace Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Wallace Pharmaceuticals Private Limited?

The authorized capital of Wallace Pharmaceuticals Private Limited is ₹5.50 Cr, and the paid-up capital is ₹2.65 Cr.

What is the compliance status of Wallace Pharmaceuticals Private Limited?

The compliance status of Wallace Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available